Health and Fitness Health and Fitness
Tue, November 22, 2011
[ Tue, Nov 22nd 2011 ] - Market Wire
Gilead Sciences wird Pharmasset, Inc. fr 11 Milliarden US-Dollar bernehmen
[ Tue, Nov 22nd 2011 ] - Market Wire
Gilead Sciences sta per acquisire Pharmasset, Inc., per 11 miliardi di dollari
[ Tue, Nov 22nd 2011 ] - Market Wire
The Law Firm of Levi & Korsinsky, LLP Launches an .. ssible Securities Laws Violations by Chemed Corp.
[ Tue, Nov 22nd 2011 ] - Market Wire
The Law Firm of Levi &;; Korsinsky Noti .. Their Investment in Hospira, Inc. of Class Actio
[ Tue, Nov 22nd 2011 ] - Market Wire
Izard Nobel LLP Announces Class Action Lawsuit Against Hospira, Inc.
[ Tue, Nov 22nd 2011 ] - Market Wire
Commencement of Share Repurchase Programme
[ Tue, Nov 22nd 2011 ] - Market Wire
AVI BioPharma to Present Company Overview at the Piper Jaffray Health Care Conference
[ Tue, Nov 22nd 2011 ] - Market Wire
Celgene Will Discontinue Phase III MAINSAIL Trial in Castrate-Resistant Prostate Cancer
[ Tue, Nov 22nd 2011 ] - Market Wire
Dendreon Announces Webcast Presentation at Upcoming Conferences
[ Tue, Nov 22nd 2011 ] - Market Wire
AMAG Pharmaceuticals, Inc. to Present at the 23rd Annual Piper Jaffray Healthcare Conference
[ Tue, Nov 22nd 2011 ] - Market Wire
Community Health Systems, Inc. Announces Completi .. g of $1.0 Billion of 8.000% Senior Notes Due 2019
[ Tue, Nov 22nd 2011 ] - Market Wire
Vertex Pharmaceuticals Announces Webcast of its P .. 23rd Annual Piper Jaffray Health Care Conference
[ Tue, Nov 22nd 2011 ] - Market Wire
Enbrel (etanercept) Patent Issued
[ Tue, Nov 22nd 2011 ] - Market Wire
SurModics to Attend Piper Jaffrayas 23rd Annual Health Care Conference on November 29
[ Tue, Nov 22nd 2011 ] - Market Wire
Cadence Pharmaceuticals Announces Completion of P .. k, Including Full Exercise of Over-Allotment Opti
[ Tue, Nov 22nd 2011 ] - Market Wire
Omeros to Present at 23rd Annual Piper Jaffray Health Care Conference
[ Tue, Nov 22nd 2011 ] - Market Wire
Alnylam to Webcast Presentation at the Piper Jaffray 23rd Annual Health Care Conference
[ Tue, Nov 22nd 2011 ] - Market Wire
Cytokinetics to Present Clinical Trial Data Relat .. 57 in Patients With Amyotrophic Lateral Sclerosis
[ Tue, Nov 22nd 2011 ] - Market Wire
Rigrodsky & Long, P.A. Announces Investigation of Chemed Corporation
[ Tue, Nov 22nd 2011 ] - Market Wire
Merck Resolves Previously Disclosed Seven-Year In .. neyas Office for the District of Massachusetts Re
[ Tue, Nov 22nd 2011 ] - Market Wire
MabCure Receives U$500,000.00 Licensing Fee as We .. lty for Its Prostate Cancer Diagnostic Technology
[ Tue, Nov 22nd 2011 ] - Market Wire
Bio-Reference Laboratories, Inc. and McKesson Spe .. Healthas Onmark GPO Execute Purchasing Agreement
[ Tue, Nov 22nd 2011 ] - Market Wire
Shire Announces Regulatory Filings in US and EU for New Manufacturing Facility
[ Tue, Nov 22nd 2011 ] - Market Wire
Accuray Incorporated to Speak at 23rd Annual Piper Jaffray Healthcare Conference
[ Tue, Nov 22nd 2011 ] - Market Wire
NuPathe to Present at the Piper Jaffray 23rd Annual Healthcare Conference
[ Tue, Nov 22nd 2011 ] - Market Wire
Gilead Sciences adquiere Pharmasset, Inc. por 11.000 millones de dlares
[ Tue, Nov 22nd 2011 ] - Market Wire
AmSurg Corp. to Present at the Piper Jaffray 23rd Annual Health Care Conference
[ Tue, Nov 22nd 2011 ] - Market Wire
Mettler-Toledo International Inc. Announces Webca .. f Presentation at J.P. Morgan SMid Cap Conference
[ Tue, Nov 22nd 2011 ] - Market Wire
Cardica Achieves Second Milestone Under Century Distribution Agreement
[ Tue, Nov 22nd 2011 ] - Market Wire
Johnson & Johnson to Participate in the Piper Jaffray 23rd Annual Health Care Conference

Johnson & Johnson to Participate in the Piper Jaffray 23rd Annual Health Care Conference


Published on 2011-11-22 07:46:50 - Market Wire
  Print publication without navigation


Johnson & Johnson to Participate in the Piper Jaffray 23rd Annual... -- NEW BRUNSWICK, N.J., Nov. 22, 2011 /PRNewswire/ --

Johnson & Johnson to Participate in the Piper Jaffray 23rd Annual Health Care Conference

[ ]

NEW BRUNSWICK, N.J., Nov. 22, 2011 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will participate in the Piper Jaffray 23rd Annual Health Care Conference on Tuesday, Nov. 29th at The New York Palace, New York, NY.  Gary Pruden, Company Group Chairman, Ethicon, will present in a session scheduled at 9:30 a.m. (Eastern Time).

The webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at [ www.investor.jnj.com ].

A webcast and podcast replay will be available approximately two hours after the live webcast.

    

SOURCE Johnson & Johnson

[ Back to top ]

RELATED LINKS
[ http://www.jnj.com ]

Contributing Sources